Lade Ayodele

Director, Global Evidence and Outcomes, Takeda Pharmaceuticals Boston

[Clarivate Epidemiology @DRG_Epi]

What’s trending at #DRG? Stay tuned for our upcoming #biomarker reports- launching soon! Sneak preview of #BRCA epidemiology report. Follow us @DRG_Epi to know more about #ALK #KRAS #EGRF #mutations #tumors @DRGinsights #drgoncology

[Lade Ayodele @LadeEpi]

#biomarkers #DRG

[JAHA @JAHA_AHA]

1 in 5 patients with acute venous thromboembolism in the United States are readmitted within 30 days https://t.co/3rpvcxRz5T

[JAHA @JAHA_AHA]

C-terminus of Thromboxane A2 Receptor may be a useful target to develop a #vaccine for managing #thrombogenesis https://t.co/Ur8dRVZdAE #weekendreading

[Alison Isherwood @DRG_Epi_Alison]

Genomic test in early #BCSM predicts who will need #chemo, preventing unnecessary RX: 9yr survival 93.9 vs 93.8 (w/out vs w/ chemo) #ASCO18

[Andrew Merron @Andrew_Merron]

The battle for the best checkpoint inhibitor combo in NSCLC continues! In the last 2 days: Phase I/II study of #Tecentriq + #Darzalex was discontinued but Phase III of #Tecentriq + #chemo improved OS. Check out all the combos with @DRGinsights Oncology Clinical Trial Monitor

[Rachel Webster @RachelMWebster1]

First @US_FDA warning, now EMA restricts #Tecentriq and #Keytruda to high PD-L1 1L #bladdercancer. Access to PDL1 tests may make this tricky! Market impact? @DRGInsights #DRGOncology #AskDRGExperts #ASCO18 https://t.co/j9vZ0qcpnS

[Alison Isherwood @DRG_Epi_Alison]

Great #breastcancer session at #ASCO about significant recurrence >25 years, I took this into account in my forecast https://t.co/9OCxFUPJCY

[Clarivate Epidemiology @DRG_Epi]

Download @DRG_epi_Lade's poster on global forecast of #NSCLC #lungcancer #Incidence at #ISPORGlasgow 2017 https://t.co/il3cdySnDv

[Lade Ayodele @LadeEpi]

Poster author discussion session. I'm at B21 #isporglasgow #NSCLC #EGFR

[Clarivate Epidemiology @DRG_Epi]

Catch @DRG_epi_Lade's poster on #incidence of #NSCLC #lungcancer at #ISPORGlasgow 2017

[Lade Ayodele @LadeEpi]

Got epi questions? Come find me at the #DRG booth 403 at #ISPORGlasgow today

[Clarivate Epidemiology @DRG_Epi]

Catch Dr. Johnson Olabisi's poster on global burden of #gastroesophageal #cancer at #IACR2017 https://t.co/8ej6CYU8wn @DRGinsights

[Mike Hughes @RWHealth_Mike]

Dementia set to become '21st century’s biggest killer' https://t.co/DExpakIxIz

[Clarivate Epidemiology @DRG_Epi]

Sign-up here to first ever global #pancreaticcancer #epidemiology forecast: https://t.co/xxWADUtaHn July 5 10am EST @DRGinsights

[Clarivate Epidemiology @DRG_Epi]

Download @DRG_Epi_Seth's #SER 2017 poster on #spinalmuscularatrophy #SMA #epidemiology here: https://t.co/gv1C3wWVkd @DRGinsights

[Clarivate Epidemiology @DRG_Epi]

77% of all prevalent cases of #diabetes worldwide are in lower-income countries @DRGinsights https://t.co/K1EpALIOsJ via @TheEconomist

[Clarivate Epidemiology @DRG_Epi]

Download Ms Goonesekera's #AAN podium presentation on global #MS #MultipleSclerosis forecast: https://t.co/wfYfitouEf @DRGinsights

[Clarivate Epidemiology @DRG_Epi]

Check out @DRG_epi_Lade 's poster on #apolipoproteinB #apoB at #SER Seattle https://t.co/yTHg2Jw6Ug

[Jason R. Lau @JLauDRG]

It's #WorldDigestiveHealthDay. Check out our white paper "Advancements in Gastroenterology: A Review of #DDW17" https://t.co/kc0xht1bV8